SE8404467D0 - Controlled-release medical preparations - Google Patents

Controlled-release medical preparations

Info

Publication number
SE8404467D0
SE8404467D0 SE8404467A SE8404467A SE8404467D0 SE 8404467 D0 SE8404467 D0 SE 8404467D0 SE 8404467 A SE8404467 A SE 8404467A SE 8404467 A SE8404467 A SE 8404467A SE 8404467 D0 SE8404467 D0 SE 8404467D0
Authority
SE
Sweden
Prior art keywords
drug
controlled
tablet
active substance
medical preparations
Prior art date
Application number
SE8404467A
Other languages
English (en)
Inventor
B Ekman
A Lindahl
Original Assignee
Ferrosan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrosan Ab filed Critical Ferrosan Ab
Priority to SE8404467A priority Critical patent/SE8404467D0/sv
Publication of SE8404467D0 publication Critical patent/SE8404467D0/sv
Priority to IE207085A priority patent/IE58263B1/en
Priority to DE8585110631T priority patent/DE3578123D1/de
Priority to EP85110631A priority patent/EP0173928B1/en
Priority to AT85110631T priority patent/ATE53490T1/de
Priority to NZ213245A priority patent/NZ213245A/xx
Priority to ZA856547A priority patent/ZA856547B/xx
Priority to NO853407A priority patent/NO169996C/no
Priority to IL76256A priority patent/IL76256A/xx
Priority to IL76257A priority patent/IL76257A/xx
Priority to AU46935/85A priority patent/AU576891B2/en
Priority to DK400685A priority patent/DK164256C/da
Priority to CA000489993A priority patent/CA1252723A/en
Priority to PH32739A priority patent/PH22119A/en
Priority to PT81092A priority patent/PT81092B/pt
Priority to US06/772,779 priority patent/US4824678A/en
Priority to ES546728A priority patent/ES8702138A1/es
Priority to FI853406A priority patent/FI87042C/sv
Priority to KR1019850006485A priority patent/KR930003114B1/ko
Priority to HU853358A priority patent/HU194495B/hu
Priority to GR852158A priority patent/GR852158B/el
Priority to JP60197517A priority patent/JP2527713B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Temperature (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
SE8404467A 1984-09-06 1984-09-06 Controlled-release medical preparations SE8404467D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations
IE207085A IE58263B1 (en) 1984-09-06 1985-08-22 Controller-release medical preparations
DE8585110631T DE3578123D1 (de) 1984-09-06 1985-08-23 Arzneipraeparate mit geregelter wirkstoffabgabe.
EP85110631A EP0173928B1 (en) 1984-09-06 1985-08-23 Controlled-release medical preparations
AT85110631T ATE53490T1 (de) 1984-09-06 1985-08-23 Arzneipraeparate mit geregelter wirkstoffabgabe.
NZ213245A NZ213245A (en) 1984-09-06 1985-08-27 Controlled-release coated pharmaceutical tablets
ZA856547A ZA856547B (en) 1984-09-06 1985-08-28 Controlled-release medical preparations
NO853407A NO169996C (no) 1984-09-06 1985-08-29 Fremgangsmaate ved fremstilling av et farmasoeytisk preparat med kontrollert utskillelse av virkestoff
IL76256A IL76256A (en) 1984-09-06 1985-08-30 Controlled-release medical preparations and method for their preparation
IL76257A IL76257A (en) 1984-09-06 1985-08-30 Sustained release tablets and method for their preparation
AU46935/85A AU576891B2 (en) 1984-09-06 1985-08-30 Biphasic release tablet with drug in polymercoat and drug in the core
DK400685A DK164256C (da) 1984-09-06 1985-09-02 Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf
PH32739A PH22119A (en) 1984-09-06 1985-09-04 Controlled release medical preparations
CA000489993A CA1252723A (en) 1984-09-06 1985-09-04 Controlled-release medical preparations
PT81092A PT81092B (pt) 1984-09-06 1985-09-05 Processo para a preparacao de composicoes medicinais de libertacao controlada
US06/772,779 US4824678A (en) 1984-09-06 1985-09-05 Controlled-release medical preparations
ES546728A ES8702138A1 (es) 1984-09-06 1985-09-05 Metodo de preparar composiciones farmaceuticas con perfil de desprendimiento controlado bifasico de sustancia activa desde un nucleo de farmaco y desde los poros de un revestimiento de membrana circundante del nucleo.
FI853406A FI87042C (sv) 1984-09-06 1985-09-05 Förfarande för framställning av kontrollerat frigivna läkemedelsprepar at
KR1019850006485A KR930003114B1 (ko) 1984-09-06 1985-09-05 2상성의 방출 단면을 가진 제어 방출되는 경구용 제제의 제조방법
HU853358A HU194495B (en) 1984-09-06 1985-09-05 Process for producing pharmaceutical compositions with controlled dissolution of active agents
GR852158A GR852158B (sv) 1984-09-06 1985-09-06
JP60197517A JP2527713B2 (ja) 1984-09-06 1985-09-06 薬物放出調節製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations

Publications (1)

Publication Number Publication Date
SE8404467D0 true SE8404467D0 (sv) 1984-09-06

Family

ID=20356934

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8404467A SE8404467D0 (sv) 1984-09-06 1984-09-06 Controlled-release medical preparations

Country Status (21)

Country Link
US (1) US4824678A (sv)
EP (1) EP0173928B1 (sv)
JP (1) JP2527713B2 (sv)
KR (1) KR930003114B1 (sv)
AT (1) ATE53490T1 (sv)
AU (1) AU576891B2 (sv)
CA (1) CA1252723A (sv)
DE (1) DE3578123D1 (sv)
DK (1) DK164256C (sv)
ES (1) ES8702138A1 (sv)
FI (1) FI87042C (sv)
GR (1) GR852158B (sv)
HU (1) HU194495B (sv)
IE (1) IE58263B1 (sv)
IL (2) IL76256A (sv)
NO (1) NO169996C (sv)
NZ (1) NZ213245A (sv)
PH (1) PH22119A (sv)
PT (1) PT81092B (sv)
SE (1) SE8404467D0 (sv)
ZA (1) ZA856547B (sv)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
DE3586600T2 (de) * 1984-02-10 1993-02-18 Benzon Pharma As Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5073381A (en) * 1988-08-15 1991-12-17 University Of Akron Amphiphilic networks
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5178868A (en) * 1988-10-26 1993-01-12 Kabi Pharmacia Aktiebolaq Dosage form
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
US5240601A (en) * 1988-11-09 1993-08-31 Chembiomed, Ltd. Affinity supports for hemoperfusion
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
JPH0794379B2 (ja) * 1990-08-07 1995-10-11 ファイザー・インコーポレーテッド 放出製剤における界面重合膜の使用方法
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
ZA933725B (en) * 1992-05-28 1993-12-15 Elan Corp Plc Tablet formulation
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
DK0809110T3 (da) * 1993-03-09 2004-05-24 Baxter Int Makromolekylære mikropartikler og fremgangsmåder til fremstilling
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064937A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
AU2277101A (en) 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
AU2276801A (en) 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
SE0100200D0 (sv) 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
KR20040018394A (ko) * 2001-07-04 2004-03-03 썬 파마슈티컬 인더스트리스 리미티드 위 정체 제어되는 약물 전달 계
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
CA2435729C (en) 2001-12-19 2005-12-13 Astrazeneca Ab New film coating
CA2479350A1 (en) * 2002-03-15 2003-09-25 Cypress Bioscience, Inc. Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
US20040228830A1 (en) * 2003-01-28 2004-11-18 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7862835B2 (en) * 2004-10-27 2011-01-04 Boston Scientific Scimed, Inc. Method of manufacturing a medical device having a porous coating thereon
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
DE602006008339D1 (en) * 2005-11-18 2009-09-17 Synhton B V Zolpidemtabletten
US7427414B2 (en) * 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
CN102440992A (zh) * 2011-12-19 2012-05-09 岳阳新华达制药有限公司 含有盐酸班布特罗和多索茶碱复方制剂及其制备方法
WO2017026950A1 (en) 2015-08-07 2017-02-16 Santa Farma Ilac San. A. S. Controlled release propiverine formulations
WO2020101586A1 (en) 2018-11-16 2020-05-22 Santa Farma İlaç Sanayi̇ A.Ş. Controlled release propiverine formulations
EP4251154A1 (en) 2020-11-27 2023-10-04 Santa Farma Ilac Sanayii A.S. Sustained release formulation compositions comprising propiverine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL108838C (sv) * 1956-03-27
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
EP0013131A3 (en) * 1978-12-27 1981-01-07 Mundipharma A.G. Pharmaceutical composition in solid dosage form, and process for its production
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system

Also Published As

Publication number Publication date
FI87042C (sv) 1992-11-25
DK164256C (da) 1992-10-19
US4824678A (en) 1989-04-25
HUT40333A (en) 1986-12-28
ZA856547B (en) 1986-04-30
DK400685A (da) 1986-03-07
FI853406A0 (fi) 1985-09-05
EP0173928A1 (en) 1986-03-12
KR930003114B1 (ko) 1993-04-19
FI87042B (fi) 1992-08-14
CA1252723A (en) 1989-04-18
HU194495B (en) 1988-02-29
EP0173928B1 (en) 1990-06-13
ATE53490T1 (de) 1990-06-15
KR860002271A (ko) 1986-04-24
GR852158B (sv) 1986-01-08
IE852070L (en) 1986-03-06
DK400685D0 (da) 1985-09-02
JPS61112013A (ja) 1986-05-30
ES8702138A1 (es) 1986-12-16
IL76257A (en) 1989-05-15
ES546728A0 (es) 1986-12-16
FI853406L (fi) 1986-03-07
IL76256A0 (en) 1986-01-31
NO169996B (no) 1992-05-25
PT81092A (en) 1985-10-01
IE58263B1 (en) 1993-08-25
PT81092B (pt) 1988-01-22
NO169996C (no) 1992-09-02
NO853407L (no) 1986-03-07
PH22119A (en) 1988-06-01
IL76256A (en) 1990-06-10
JP2527713B2 (ja) 1996-08-28
AU576891B2 (en) 1988-09-08
AU4693585A (en) 1986-03-13
DK164256B (da) 1992-06-01
DE3578123D1 (de) 1990-07-19
NZ213245A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
SE8404467D0 (sv) Controlled-release medical preparations
HUT59321A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
IE883810L (en) Sustained release pharmaceutical compositions
KR880001289A (ko) 서방성 제제 및 그의 제조방법
DE3855852T2 (de) Kugelförmige Granula mit Kern sowie deren Herstellung
HUT56267A (en) Process for producing pharmaceutical compositions having controlled release of active ingredient
ES2001897A6 (es) Procedimiento para la fabricacion de una tableta de liberacion controlada
DE3767600D1 (de) Ibuprofen-formulation mit verzoegerter wirkstoffabgabe.
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
DE220143T1 (de) Pharmazeutische zubereitungen von metoprolol mit kontrollierter wirkstoff abgabe, verfahren zu ihrer herstellung und verwendung dieser zubereitungen.
DE59806578D1 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen
EP0171528A3 (en) Controlled release pharmaceutical preparations
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
AU574220B2 (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
ES8100880A1 (es) Procedimiento para la fabricacion de una forma de accion re-tardada mejorada.
ES8704080A1 (es) Metodo para producir una tableta farmaceutica revestida esencialmente con un terpolimero de poli (cloruro de vinilo) poli (acetato de vinilo) y poli (alcohol vinilico)
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.